Skip to search.
 BSE Up 0.12% NSE Up 0.15%
Streaming
Ticker Tape: On

More On TPIV

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

TapImmune, Inc. (TPIV)

-OTC BB

0.04 19 Jun 1:23AM|Pre-Market : NaN

Add to Portfolio
Prev Close:0.04
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:2.66
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.03 - 0.16
Volume:0
Avg Vol (3m):1,047,280
Market Cap:3.25M
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for TPIV at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

TapImmune Inc., a development stage company, engages in the discovery and development of immunotherapeutics for the treatment of cancer, as well as therapies for infectious diseases, autoimmune disorders, and transplant tissue rejection. View More
Company Profile
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback